Oversea-Chinese Banking Corp (OCBC)’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Oversea-Chinese Banking Corp (OCBC)'s BIIB Position: Q2 2026 in Review
Oversea-Chinese Banking Corp (OCBC) reduced its Biogen (BIIB) stake by 15% in Q2 2026, selling an estimated $1.07M and leaving 31,867 shares worth $6.89M. The position accounts for 0.15% of the portfolio, ranked #113.
Oversea-Chinese Banking Corp (OCBC) first reported a position in BIIB in Q4 2022 and has held it in 15 quarters since. The position peaked at $7.33M in Q1 2025. 684 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Oversea-Chinese Banking Corp (OCBC) held 31,867 shares of Biogen worth $6.89M as of Q2 2026.
- Oversea-Chinese Banking Corp (OCBC) sold 5,598 Biogen shares in Q2 2026, an estimated $1.07M.
- Biogen made up 0.15% of Oversea-Chinese Banking Corp (OCBC)'s portfolio in Q2 2026, its #113 holding.
- Oversea-Chinese Banking Corp (OCBC) first reported a position in Biogen in Q4 2022 and has held it in 15 quarters since.
- Oversea-Chinese Banking Corp (OCBC)'s Biogen position peaked at $7.33M in Q1 2025.
- 684 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q2 2026, filed 11 Aug 2026.